Endocrinology News and Research

Latest Endocrinology News and Research

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Research presented today by UT Southwestern cardiologists at the annual American Heart Association (AHA) Scientific Sessions 2020 showed that Black and Hispanic people were more likely to be hospitalized with COVID-19 than white patients, and that nonwhite men with cardiovascular disease or risk factors were more likely to die.

18 Nov 2020

Study finds more than half of in-hospital COVID-19 deaths among Black, Hispanic patients

More than half of all in-hospital deaths due to COVID-19 during the first six months of 2020 were among Black and Hispanic patients, according to a new study led by researchers at the Stanford University School of Medicine and Duke University.

17 Nov 2020

ECG abnormalities can predict COVID-19 mortality

A team of scientists from New York University Langone Medical Center, USA, has revealed that the clinical severity of hospitalized patients with coronavirus disease 2019 (COVID-19) can be predicted by analyzing the level of troponin elevation and electrocardiographic (ECG) abnormalities. The study is currently available on the medRxiv preprint server.

17 Nov 2020

Two-thirds of older Americans would not seek treatment for depression, new poll shows

A new nationwide poll, the GeneSight Mental Health Monitor, shows that nearly two-thirds (61%) of Americans age 65 or older who have concerns about having depression will not seek treatment.

17 Nov 2020

New program can remotely improve cardiovascular health for broad population of patients

Despite being known risk factors for poor cardiovascular outcomes, blood pressure and low-density lipoprotein (LDL) cholesterol remain undertreated among a large proportion of patients.

17 Nov 2020

Overweight and obesity in younger people associated with higher risk of severe COVID-19

Being younger doesn't protect against the dangers of COVID-19 if you are overweight, according to a new study from UT Southwestern.

17 Nov 2020

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Researchers from the Huazhong University of Science and Technology and Shanghai Jiao Tong University, China, recently built a proteome microarray with 20 out of the 28 predicted SARS-CoV-2 proteins to help understand IgM/IgG responses specific to SARS-CoV-2.

17 Nov 2020

Study identifies new factor that offers potential strategy for treating obesity

Obesity is a serious global health problem and a risk factor for diseases such as type II diabetes, heart disease and fatty liver disease.

17 Nov 2020

Investigational drug helped improve heart health in patients with chronic conditions

The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

A novel diabetes medication significantly reduces the risk of hospitalization for heart failure, heart attack and stroke, in patients with Type 2 diabetes and chronic kidney disease, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.

17 Nov 2020

Study: Novel drug may treat reproductive health problems in women

A drug that acts via the natural 'kisspeptin' hormone system in the body has the potential to treat reproductive health problems in women, according to a new study.

17 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Short bursts of physical exercise induce changes in the body's levels of metabolites that correlate to, and may help gauge, an individual's cardiometabolic, cardiovascular and long-term health, a study by Massachusetts General Hospital has found.

16 Nov 2020

Mediterranean diet may help reduce the physiological effects of stress

Even before the pandemic and the presidential election, Americans reported some of the highest perceived levels of stress in the world, according to the American Psychological Association.

16 Nov 2020

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Even when risk factors associated with cardiovascular disease are optimally controlled, adults with Type 2 diabetes still have a greater risk of developing cardiovascular disease compared to the general population, according to new research published today in the American Heart Association's flagship journal Circulation.

16 Nov 2020

Modifiable risk factors in the first 1000 days of life predict higher adiposity and cardiometabolic risk

Early life risk factors in the first 1000 days cumulatively predict higher obesity and cardiometabolic risk in early adolescence, according to new research led by the Harvard Pilgrim Health Care Institute.

16 Nov 2020

Metabolic biomarkers could predict COVID-19 severity

A new study suggests that metabolic biomarkers could possibly predict the severity of COVID-19 in patients.

16 Nov 2020

Goblet cells are prime target for SARS-CoV-2, study finds

A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Previous
1
...
89
90
91
92
93
94
95
...
1479
Next

Endocrinology News and Research

Latest Endocrinology News and Research

Study highlights the disproportionate burden of COVID-19 among Black, Hispanic patients

Study finds more than half of in-hospital COVID-19 deaths among Black, Hispanic patients

ECG abnormalities can predict COVID-19 mortality

Two-thirds of older Americans would not seek treatment for depression, new poll shows

New program can remotely improve cardiovascular health for broad population of patients

Overweight and obesity in younger people associated with higher risk of severe COVID-19

SARS-CoV-2-specific IgM / IgG responses accurately predict COVID-19 outcome

Study identifies new factor that offers potential strategy for treating obesity

Investigational drug helped improve heart health in patients with chronic conditions

Novel drug reduces the risk of cardiovascular events for patients with Type 2 diabetes, kidney disease

Study: Novel drug may treat reproductive health problems in women

Lower dairy intake may be beneficial for people with metabolic syndrome

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Short bursts of exercise elicit widespread changes in the body's levels of metabolites

Mediterranean diet may help reduce the physiological effects of stress

Cardiovascular risk factor control is vital for adults with Type 2 diabetes

Modifiable risk factors in the first 1000 days of life predict higher adiposity and cardiometabolic risk

Metabolic biomarkers could predict COVID-19 severity

Goblet cells are prime target for SARS-CoV-2, study finds

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Endocrinology News and Research

Latest Endocrinology News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in